Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Oct 19, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to help young adults in Baltimore improve their economic stability and reduce the risk of HIV infection. The study will involve about 780 participants aged 18 to 24 who identify as African-American and have faced economic challenges in the past year. Participants will be randomly placed into two groups: one group will receive text messages with job openings, while the other group will get the same job information plus additional support like educational sessions on HIV prevention, mentorship, and small financial grants to help with employment.
To be eligible for this study, you must be between 18 and 24 years old, sexually active in the past year, and able to receive text messages on a mobile phone. The goal is to see if providing more resources and education can help young adults not only find jobs but also make safer choices regarding their health. If you join, you can expect to receive helpful information and support that could positively impact your life.
Gender
ALL
Eligibility criteria
- Inclusion criteria are:
- • Aged 18-24
- • African-American
- • Economically-vulnerable in past 12 months
- • Sexually active in past 12 months
- • Living in Baltimore
- • Has access to mobile phone with text messaging
- Exclusion criteria are:
- • Aged 17 or younger
- • Older than 24 years
- • Unwilling to provide consent for study participation
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Larissa Jennings Mayo-Wilson, PhD MHS
Principal Investigator
University of North Carolina, Chapel Hill
Adriana Parker, MPH
Study Director
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported